TransCode Therapeutics logo

TransCode Therapeutics

RNAZ | NASDAQ
Chart Builder DCF Calculator
$1.35
+$0.03 (+2.27%)
At close: Nov 16, 2026, 4:00 PM ET
$1.37
+$0.02 (+1.48%)
After-hours: Nov 16, 2026, 7:30 PM ET
+2.27%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 14, 2026
35.5
+5.0 pts
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #634/1021 (Top 62%)

Key Statistics

Market Data

Market Cap $1.43M
1D Range
1.29 1.47
52W Range
1.29 12.34

Valuation (TTM)

PE -0.03
PB 0.01
EV/EBITDA 0.15

Valuation (NTM)

Forward PE N/A
Forward PEG 0.00
Price Target $0.00
Loading financial charts...

Profile

TransCode Therapeutics, Inc. is a biopharmaceutical firm dedicated to pioneering and marketing therapeutic agents and diagnostic tools specifically aimed at combating and detecting metastatic disease....

Sector Healthcare
Industry Biotechnology
Employees 12
IPO Date Jul 8, 2021
Fiscal Year January - December

Latest News

No news articles available yet.

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.